Allopurinol Does Not Slow Kidney Function Decline in Key Subgroups
Investigators performed post hoc analyses of the CKD-FIX trial, stratifying patients by their CKD stage and serum urate level at baseline.
Investigators performed post hoc analyses of the CKD-FIX trial, stratifying patients by their CKD stage and serum urate level at baseline.
In contrast to CARES, FAST found that treatment with febuxostat was not associated with an increase in cardiovascular or all-cause death compared with allopurinol in patients with gout.
Fracture prevention efforts should be considered in patients with CKD of any age, according to investigators.
Among individuals with chronic kidney disease, the presence of anemia doubled the risk for hyperuricemia.
Gout that develops in kidney transplant recipients increases their risk of worse outcomes, according to 2 new studies.
There is increasing evidence to support lower serum uric acid thresholds of at least 6 mg/dL in patients with gout to improve survival.